During a routine health maintenance examination, a 45-year-old male is noted to have a blood pressure of 158/96 mmHg. A review of his electronic medical record reveals home blood pressure logs consistently in the 150s/90s over the past three months. The patient takes no prescription medications and reports no significant past medical history. He mentions experiencing intermittent muscle cramps in his lower extremities over the last several weeks but otherwise feels well. Physical examination today is unremarkable aside from the elevated blood pressure. Initial laboratory studies show a serum sodium level of 144 mEq/L and a serum potassium level of 3.0 mEq/L. Which of the following is the most appropriate next step in laboratory evaluation?
- Measurement of plasma aldosterone concentration and plasma renin activityCevap
- BIntravenous saline loading test
- CComputed tomography of the adrenal glands
- DMeasurement of 24-hour urinary fractionated metanephrines
- ERepeat measurement of serum basic metabolic panel in 4 weeks
Cevap
The correct answer is the measurement of plasma aldosterone concentration and plasma renin activity.
The correct answer is the measurement of plasma aldosterone concentration and plasma renin activity. This patient presents with hypertension and unprovoked hypokalemia (serum potassium of 3.0 mEq/L without diuretic use). This classic presentation is highly suspicious for primary hyperaldosteronism (Conn syndrome). The diagnostic algorithm for primary hyperaldosteronism mandates a stepwise approach. The most appropriate initial step in laboratory evaluation is a screening biochemical test: the ratio of plasma aldosterone concentration (PAC) to plasma renin activity (PRA). A significantly elevated PAC/PRA ratio (typically > 20) with a PAC > 15 ng/dL is considered a positive screen and warrants further confirmatory testing.
Adım Adım Çözüm
Anahtar Kavram
The initial evaluation of suspected primary hyperaldosteronism (hypertension with unprovoked hypokalemia) requires biochemical screening with a plasma aldosterone concentration to plasma renin activity ratio before proceeding to confirmatory testing or imaging.